Naked Short Web Site Announces TSTC, MAGOY, ACUR, VITFF, CCTC Have Been Removed From Threshold Lists Today
May 11, 2010 /M2 PRESSWIRE/ BUYINS.NET, www.buyins.net , announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists. Telestone Technologies (NASDAQ: TSTC), MAN AG (OTC: MAGOY), Acura Pharmaceuticals (NASDAQ: ACUR), Victoria Gold Corp (OTC: VITFF) and Clean Coal Technologies (OTC: CCTC). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
Telestone Technologies Corporation (NASDAQ: TSTC) provides access network solutions primarily in the Peoplea�s Republic of China. Its access network solutions include the research and development, and application of access network technology. The company designs and sells electronic equipments, such as WFDS products, RFPA products, passive components, repeaters, radio frequency peripherals, and base station antennas used to provide access network solutions for 2G, 3G, broadband access, and CATV networks. It also provides project design, project management, installation, maintenance, and other after-sales services. In addition, Telestone offers coverage solutions, which cover indoor and outdoor environments, including hotels, residential estates, office buildings, airports, exhibition centers, underground stations, highways, and tunnels, to the telecommunications industry. Further, it provides 3D solution, a third generation indoor coverage solution, which utilizes fiber technology in the radio frequency signal distribution to transmit high speed data signals; and the PHS system optimization solution that addresses network coverage, network planning, network capacity, and network disturbance issues of wireless networks. The company was founded in 1987 and is headquartered in Beijing, the Peoplea�s Republic of China. There is no longer a failure to deliver in shares of TSTC.
MAN SE (OTC: MAGOY), together with its subsidiaries, manufactures and sells commercial vehicles, turbo machinery, diesel engines, and gear systems principally in Germany. It offers trucks for military and public sector uses; combustion ignition and spark-ignited engines for vehicles, boats, and power generation; and buses and coaches. The company also provides two-stroke and four-stroke diesel engines for marine industry; and engines for electricity generation at power plants. In addition, MAN SE offers turbo compressors, industrial turbines, and chemical reactor systems, as well as special gears and components of propulsion technology and test systems. It also markets its products in rest of Europe, Asia, America, Africa, and Australia and Oceania. The company, formerly known as MAN Aktiengesellschaft, was founded in 1758 and is headquartered in Munich, Germany. There is no longer a failure to deliver in shares of MAGOY.
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion Technology, Impede Technology, and other technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, decongestants, and various other opioid analgesics. The companya�s lead product candidate, Acurox Tablet, is an orally administered immediate release tablet containing oxycodone HCl as its active analgesic ingredient. Its opioid analgesic product candidates are used to relieve pain while discouraging common methods of opioid product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. The company is also investigating and developing mechanisms to incorporate abuse deterrent characteristics into abused and misused pharmaceutical products through laboratory testing of a product candidate developed with its Impede Technology, which is intended to inhibit the conversion of pseudoephedrine HCl into methamphetamine. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize various opioid analgesic products utilizing the companya�s proprietary Aversion Technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois. There is no longer a failure to deliver in shares of ACUR.
Victoria Gold Corp. (OTC: VITFF) engages in the acquisition, evaluation, exploration, and development of gold properties in the United States. Its core projects include the Cove, Mill Canyon, Big Springs, and Santa Fe. Victoria Gold Corp., formerly known as Victoria Resource Corporation, was founded in 1981 and is based in Toronto, Canada. There is no longer a failure to deliver in shares of VITFF.
Clean Coal Technologies, Inc. (OTC: CCTC) owns a patented technology to reduce the contaminants and pollutants created by the burning of coal through a patented multi-stage process that transforms coal with various levels of impurities, contaminants, and other polluting elements into a low polluting fuel. It has a trade mark aPRISTINEa� for a range of applications, including coal-fired power stations, chemical byproduct extraction, and as a source fuel for coal to liquid technologies. The company was founded in 2007 and is based in Coral Springs, Florida. There is no longer a failure to deliver in shares of CCTC.
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net